Clinical Study

A Phase 1, Multiple-Dose, Open-Label Study To Evaluate The Safety,Tolerability, And Pharmacokinetics Of Olz/Sam In Pediatric Subjects (10-12 Years Old) With Bipolar I Disorder

Posted Date: Jun 15, 2021

  • Investigator: Melissa Delbello
  • Specialties: Bipolar Disorder, Psychiatry/Psychology
  • Type of Study: Drug

A study to evaluate the safety, tolerability, and pharmacokinetics of the study drug in pediatric subjects (10 to 12 years old) with bipolar I disorder.

Criteria:

10-12 Year Old With Bipolar I Disorder

Keywords:

Bipolar I Disorder, Pk, Pediatric

For More Information:

Raechel Cooley, B.A
513-558-6205
cooleyra@ucmail.uc.edu